AstraZeneca Covid-19 vaccine shows antibody levels comparable to recovered patients July 20, 2020 Auto Bot AstraZeneca, AZD1222, BioPharma, biopharma nl, London, SARS-CoV-2, U.K., Vaccines 0 The company announced the publication of interim data from the Phase I/II study of a vaccine it is developing with the University of Oxford. The news comes the week after Moderna announced the publication of data for its vaccine.